Centre Relaxes CME Rules for Medtech Firms Under UCMPMD Code

The Centre has relaxed CME rules, medtech firms, and UCMPMD code requirements, making it easier for companies to organise training and educational programmes for healthcare professionals.

The revised policy aims to reduce approval delays while ensuring ethical practices remain in place. Industry experts believe the move will support skill development, improve access to advanced medical technology, and strengthen collaboration between medical device companies and healthcare providers.

Under the updated guidelines issued by the Department of Pharmaceuticals, medical technology companies will no longer need prior government approval to sponsor overseas training programmes if similar facilities, expertise, or equipment are not available in India. Earlier, companies were required to seek approval before arranging such educational activities abroad, often leading to procedural delays.

The changes fall under the Uniform Code for Marketing Practices in Medical Devices, which was introduced to encourage responsible and transparent engagement between medtech companies and healthcare professionals. The code is designed to ensure that educational support and marketing activities follow ethical marketing practices and avoid undue influence.

Although the rules have been eased, companies are still expected to maintain accountability. Firms must keep proper records explaining why overseas training was necessary and demonstrate that equivalent learning opportunities were unavailable within India. These documents may be reviewed during audits or compliance inspections.

Also Read: Lilly Supports Haryana Crackdown on Fake Mounjaro Drug Networks

Industry representatives say the updated norms could particularly benefit training related to advanced medical devices that require specialised technical knowledge. Many high-end technologies are developed and demonstrated at global centres, making international exposure important for doctors, technicians, and medical staff.

The policy may also support smaller medtech companies that previously faced challenges due to lengthy approval procedures. Faster access to educational programmes could encourage wider adoption of new technologies in hospitals and diagnostic centres.

Experts, however, note that strong oversight will remain important to ensure that educational events are not used as indirect promotional platforms. Regulators are expected to closely monitor compliance to maintain transparency and ethical conduct.

The revised framework reflects the government’s effort to encourage healthcare innovation, professional learning, and industry growth while preserving responsible marketing practices within India’s expanding medical technology sector.